MRGPRX2 and glioblastoma: Initial hit compound characterization confirmed MRGPRX2-blocking activity in an orthogonal assay measuring inhibition of Gq protein-mediated calcium mobilization in a different cell line, an MRGPRX2-overexpressing glioblastoma cell line (LN229).